SCHEMBL25980465

SCHEMBL25980465

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4c3sc3cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 5/20 0.38
ABCG2 Q9UNQ0 2/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 4/20 0.33
CYP1A2 P05177 4/20 0.33
CYP3A4 P08684 4/20 0.33
CYP2D6 P10635 4/20 0.33
CYP2C9 P11712 4/20 0.33
CYP2C19 P33261 4/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
TSHR P16473 3/20 0.33
PDE5A O76074 2/20 0.33
GLA P06280 2/20 0.33
KDM1A O60341 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980468 0.99 LIMK1 (0.38) LIMK1ABCG2ALDH1A1MAPTHPGD
SCHEMBL25979723 0.88 PRKDC (0.36) LIMK1ABCG2MAPTALOX5ATM
SCHEMBL26779421 0.87 ALOX5 (0.41) LIMK1ABCG2ALDH1A1MAPTHPGD
SCHEMBL25979547 0.87 PRKDC (0.36) ALDH1A1MAPTHPGDCYP1A2CYP3A4
SCHEMBL22161493 0.86 LIMK1 (0.39) LIMK1ALDH1A1MAPTHPGDCYP1A2
SCHEMBL26759868 0.85 LIMK1 (0.40) LIMK1ALDH1A1MAPTHPGDKDM4E
SCHEMBL26154359 0.85 LIMK1 (0.39) LIMK1ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21866971 0.85 ALOX5 (0.33) ALDH1A1MAPTHPGDCYP1A2CYP3A4
SCHEMBL26416759 0.83 LIMK1 (0.40) LIMK1ALDH1A1MAPTHPGDCYP1A2
SCHEMBL25980421 0.83 LIMK1 (0.33) LIMK1ABCG2ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 LIMK1 528/4885ABCG2 2304/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.